主办单位欢迎词

各位朋友

我们竭诚欢迎您参加2017年7月10日至13日将于波士顿举办的Drug Discovery and Therapy World Congress 2017。

本年会招待了全球屈指一数的学术界及产业界科学家,针对药物开发与治疗的最新动向进行对话。分成40项主题的会议将包含多达400个演讲,此外还有海报发表等丰富活动的大型会议。过去数年本公司在阿拉伯联合大公国也举办过类似的系列会议,获得了盛大的成功之外,包含超过22名诺贝尔奖得主在内的许多顶尖国际学者都曾经在此发表演说。

2017年会预计将涉及下列药物开发与治疗相关主题。药物研究开发、转译医疗、再生医疗、实现技术、结构生物学、药物运输与标的设定、抗感染药物、生物制剂、中枢神经疾病的药物开发与治疗、糖尿病及肥胖症的开发与治疗、妇女健康药物开发与治疗、临床前研究的药物开发、心血管疾病的药物开发与治疗、肿瘤学、流程化学与药剂制造、肺部疾病的药物开发与治疗、病患治疗及照护的近年进展、炎症与免疫学、革新药物开发与奈米科技、药物生物科技、蛋白质体学及生物信息体学、药物基因体学、蛋白质及胜肽科学、药物代谢、医学化学的焦点主题、医疗影像、HIV研究的焦点主题、In-silico药物设计与In-silico筛选、高通量筛选及实验室自动化、药剂标的中焦点主题、天然产品的焦点主题、生物活性化合物的立体选择合成、分光法及近年进展、药物开发的产学合作。

本年会的目的在于针对药物开发与治疗的科学及技术的快速进步提供许多有趣的观点见解,连带的也给予科学家及医师新的机会与挑战。

在波士顿这个迷人又知性的城市所举办的本年会,是聚集各领域世界领导者于一堂的重要活动。我们衷心期盼您的参与。

On behalf of the Organizing Committee
DDTWC 2017


ABOUT THE PRESIDENTS



PROF. ATTA-UR-RAHMAN, FRS
UNESCO Science Laureate

Drug Discovery and Therapy World Congress 2017

Prof. Atta-ur-Rahman obtained his Ph.D. in organic chemistry from Cambridge University (1968). He has 1056 publications in several fields of organic chemistry including 740 research publications, 37 international patents, 69 chapters in books and, 210 books published largely by major U.S. and European presses. He is the Editor-in-Chief of four European Chemistry journals. He is Editor of the world's leading encyclopedic series of volumes on natural products "Studies in Natural Product Chemistry" 50 volumes of which have been published under his Editorship during the last two decades. Eighty two students have completed their Ph.D. degrees under his supervision.

Prof. Rahman is the first scientist from the Muslim world to have won the prestigious UNESCO Science Prize (1999) in the 35 year old history of the Prize. He was elected as Fellow of Royal Society (London) in July 2006. He has been conferred honorary doctorate degrees by many universities including the degree of Doctor of Science (Sc.D.) by the Cambridge University (UK) (1987), Honorary degree of Doctor of Education by Coventry University UK (2007), Honorary D.Sc. degree by Bradford University (2010), Honorary Ph.D. by Asian Institute of Technology (2010) and Honorary Doctorate from King of Malaysia (University of Technology, Mara, 2011). He was elected Honorary Life Fellow of Kings College, Cambridge University, UK in 2007. Prof. Atta-ur-Rahman was conferred the TWAS (Italy) Prize for Institution Building in October 2009 in recognition of his contributions for bringing about revolutionary changes in the higher education sector in Pakistan. The Austrian government has honoured him with its highest civil award ("Grosse Goldene Ehrenzeischen am Bande") (2007) in recognition of his eminent contributions. He is President of Network of Academies of Sciences of Islamic Countries (NASIC), Foreign Fellow of Korean Academy of Sciences, and Foreign Fellow of the Chinese Chemical Society. Prof. Atta-ur-Rahman has won the International Scientific Corporation Award by Chinese Academy of Science (CAS) for building scientific collaborations between China and Pakistan (2014), has been awarded prestigious "Einstein Professorship" by Chinese Academy of Sciences (CAS), 2013 and has been awarded highest award "Friendship Award of China" on September 28, 2014.He has recently been appointed as Consultant, Education Forum Asia (2015-2020) and Foreign Member of Chinese Academy of Sciences (2015).

Prof. Atta-ur-Rahman is the President of Network of Academies of Science in Countries of the Organization of Islamic Conference (NASIC). Prof. Atta-ur-Rahman has been elected as the President of the Pakistan Academy of Sciences twice from 2003-2006 and 2011 - 2014. He was the Federal Minister for Science and Technology (14th March, 2000 - 20th November, 2002), Federal Minister of Education (2002) and Chairman of the Higher Education Commission with the status of a Federal Minister from 2002-2008. Prof. Atta-ur-Rahman was the Coordinator General of COMSTECH, an OIC Ministerial Committee comprising the 57 Ministers of Science & Technology from 57 OIC member countries from 1996 to 2012. He is Distinguished National Professor as well as Professor Emeritus at Karachi University.

In recognition of his global outstanding services to the development of Science and Technology the largest university in Malaysia, University of Technology Mara, Malaysia UiTM, has established an institution entitled, "Atta-ur-Rahman Institute of Natural Product Discovery (RiND)" in 2013., The National University of Science and Technology (NUST) has also established an Institute "Atta-ur-Rahman School of Applied Biosciences (ASAB)" at their university in Islamabad in 2011.

Prof. Dr. Atta-ur-Rahman is the most decorated scientist of Pakistan having won four civil awards by the government of Pakistan, including Tamgha-i-Imtiaz (1983), Sitara-i-Imtiaz (1991), Hilal-i-Imtiaz (1998), and the highest national civil award Nishan-i-Imtiaz (2002).



Ferid Murad
Nobel Laureate M.D.

Drug Discovery and Therapy World Congress 2017

Ferid Murad, Nobel Laureate M.D. is Director Emeritus at the Brown Foundation Institute of Molecular Medicine for the prevention of Human Diseases, Director of the IMM Center for Cell Signaling, Regental Professor and John S. Dunn Sr. Distinguished Chair in Physiology and Medicine, Texas Nobel Scholar at the University of Texas at Houston, and Director of the UT Health Science Center at Houston Program in Intracellular Signaling.

Dr. Murad completed his undergraduate work at DePauw University and received his M.D. and Ph.D. from Case Western Reserve University. He had a medical residency at Massachusetts General Hospital and a fellowship at NIH in the Heart Institute. He was on the faculty at the University of Virginia 1970-81 as Director of the Clinical Research Center and Director of the Division of Clinical Pharmacology with appointments in Medicine and Pharmacology. He was Chief of Medicine at Palo Alto Veterans Hospital 1981-88, Associate Chairman of Medicine 1982-86 and Chairman of Medicine 1986-88 at Stanford University. He was Vice President of Research and Development at Abbott Laboratories 1988-93 and Professor at Northwestern University.

Dr. Murad has been active in both academic medicine and industry throughout his distinguished career. He has founded and co-founded five biotechnology companies and has advised many cities and government leaders about technology development. His work has concentrated on the field of cell signaling and signal transduction systems.

In 1998, Dr. Murad received the Nobel Prize in Medicine for his work with nitric oxide - a colorless, odorless gas that signals blood vessels to relax and widen, which in turn lowers blood pressure. He continues research which leads to a better understanding of how information is transmitted between cells.

Among his many other awards and honors, Dr. Murad received the prestigious Albert and Mary Lasker Basic Medical Research Award in 1996, the American Heart Association Ciba Award in 1988, and the Baxter Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges in 2000. He also received the American Society of Clinical Pharmacology Distinguished Research Prize in 2005 and the President"s Scholar Award from the University of Texas-Houston Health Science Center in 2006.

He is a member of the National Academy of Sciences, Institute of Medicine of the National Academy of Sciences, Fellow of the American Academy of Arts and Sciences, Texas Academy of Medicine, and Engineering and Science Technology. He is also a member of several foreign academies and is an Honorary or Adjunct Professor at a number of universities. Dr. Murad also serves on the Board of Directors and Scientific Advisory Boards of a number of public and private companies and various foundations and universities. About 140 trainees have worked in his laboratories who are currently academic or pharmaceutical industry leaders around the world.